SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-24-036716
Filing Date
2024-04-26
Accepted
2024-04-26 17:10:20
Documents
1
Period of Report
2024-06-20

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ea0204514-def14a_unicyc.htm DEF 14A 768064
  Complete submission text file 0001213900-24-036716.txt   769120
Mailing Address 4300 EL CAMINO REAL, SUITE 210 LOS ALTOS CA 94022
Business Address 4300 EL CAMINO REAL, SUITE 210 LOS ALTOS CA 94022 650-384-0642
Unicycive Therapeutics, Inc. (Filer) CIK: 0001766140 (see all company filings)

IRS No.: 813638692 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40582 | Film No.: 24885169
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)